Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02978833 · ClinicalTrials.gov registry record · Phase 4
Platelet-rich Plasma vs. Whole Blood for Gluteus Medius Tendinopathy
A Phase 4 study, sponsored by Hospital for Special Surgery, New York.
- Terminated
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT02978833: Clinical Trial Phase 4 study, sponsored by Hospital for Special Surgery, New York.
NCT02978833 is a Phase 4 study that was terminated before completion, run by Hospital for Special Surgery, New York. The registered enrollment target is 2 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02978833, a Phase 4 study, was terminated before completion, sponsored by Hospital for Special Surgery, New York.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
Gluteus medius tendinopathy, which is often referred to as Greater Trochanteric Pain Syndrome, is characterized by pain in the lateral aspect of the hip that is aggravated by side lying, stair climbing, and walking. Treatment is currently limited to lifestyle modifications, corticosteroid injections, physical therapy, and open and endoscopic surgical repair. Platelet rich plasma (PRP) injections contain important growth factors that are essential in the healing and tissue formation processes. However, the extent to which PRP is more efficacious than whole blood in tendinopathy remains unclear. In this double-blind randomized trial, patients will be allocated to receive either a PRP or whole-blood injection. Post-procedure assessments will occur at 6 weeks, 3 months, 6 months, 9 months, and 1 year.
Primary Outcome
The Numerical Rating Scale for Pain will be used, where 0=no pain and 10=worst pain. A higher number represents more pain.
Interventions
- DEVICE Ultrasound
- BIOLOGICAL PRP
- BIOLOGICAL Whole Blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-10-01 |
| Est. Completion | 2017-06 |
| Phase | Phase 4 |
Why NCT02978833 stopped before completion
NCT02978833 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Ultrasound is the first listed.
NCT02978833 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02978833 about?
NCT02978833 is a clinical study titled "Platelet-rich Plasma vs. Whole Blood for Gluteus Medius Tendinopathy". Gluteus medius tendinopathy, which is often referred to as Greater Trochanteric Pain Syndrome, is characterized by pain in the lateral aspect of the hip that is aggravated by side lying, stair climbing, and walking. Treatment is currently limited to lifestyle modifications, corticosteroid injections...
What is the current status of trial NCT02978833?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2013-10-01. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02978833?
The interventions under investigation include: Ultrasound (DEVICE), PRP (BIOLOGICAL), Whole Blood (BIOLOGICAL).
Who is sponsoring clinical trial NCT02978833?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02978833's enrollment target sits among peer trials
2 1998th of 2000 higher than 1 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI